Log in
Enquire now
Nocion Therapeutics

Nocion Therapeutics

Nocion Therapeutics is developing positively charged versions of "caines" -- broadly acting intracellular sodium channel blockers

OverviewStructured DataIssuesContributors
Is a
Organization
Organization
Company
Company
B2X
B2B
B2B
0
Legal Name
Nocion Therapeutics, Inc.
Company Operating Status
Active
Country
United States
United States
Crunchbase URL
crunchbase.com/organiz...apeutics
Email Address
careers@nociontx.com
0
info@nociontx.com
0
Founder
‌
Clifford J. Woolf
0
‌
Bruce Bean
0
‌
Bruce Levy
0
Full Address
100 Beaver Street, Suite 308 Waltham, MA 02453
0
Industry
Biomedical engineering
Biomedical engineering
Engineering
Engineering
Technology
Technology
Biology
Biology
Biotechnology
Biotechnology
Ophthalmology
Ophthalmology
0
Dermatology
Dermatology
0
Investors
F-Prime Capital Partners
F-Prime Capital Partners
Partners Innovation Fund
Partners Innovation Fund
BioInnovation Capital
BioInnovation Capital
Canaan
Canaan
Latest Funding Round Date
April 18, 2019
Latest Funding Type
Series A
Series A
LinkedIn URL
@company/nocion-therapeutics-inc
Location
Cambridge, Massachusetts
Cambridge, Massachusetts
Waltham, Massachusetts
Waltham, Massachusetts
0
United States
United States
Number of Employees (Ranges)
1 – 10
0
Patents Assigned (Count)
7
Pitchbook URL
pitchbook.com/profiles...266656-87
Total Funding Amount (USD)
54,000,000
Official Website
nociontx.com

Find more companies like Nocion Therapeutics

Use the Golden Query Tool to find similar companies in the same industry, location, or by any other field in the Knowledge Graph.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.